Hansen Medical, Inc. (
Q2 2011 Earnings Call
August 3, 2011, 5:00 p.m. ET
Matt Clawson – IR, Allen & Caron Inc.
Bruce Barclay – President and CEO
Peter Mariani - CFO
Brooks West – Piper Jaffray
Jeffrey Cohen – Laden, Burke, Thalmann Financial Services
Bill Carlisle – Morgan Stanley
Good day Ladies and Gentlemen, and thank you for standing by. Welcome to the Hansen Medical 2011 second quarter and six month results conference call. [Operator Instructions].
This call is being recorded today, Wednesday, August 3
of 2011, and I’d now like to turn the conference over to Matt Clawson of Allen and Caron. Please go ahead.
Thank you, Alicia. Good afternoon everyone. Welcome to Hansen Medical’s 2011 second quarter results conference call. With us today are Hansen Medical’s President and CEO, Bruce Barclay and the company’s Chief Financial Officer, Pete Mariani.
Before I turn the call over to management, please remember that our prepared remarks and responses to questions will contain forward-looking statements that are subject to a number of risks and uncertainties. Examples of such statements includes statements about the expected timing of commercial availability of our Magellan Vascular Robotic System, the level of clinical interest in our Vascular Robotic System, and expectations regarding commercial success of our Lynx irrigated catheter.
Important factors could cause actual results to differ materially from those indicated by forward-looking statements, include among others, the development of new products and applications of technology are subject to design, engineering, and manufacturing challenges that could delay clinical studies, regulatory filings, and commercialization, potential safety and regulatory issues could delay, suspend, or terminate clinical studies, regulatory approvals, [technical difficulties].